The role of quantitative HBsAg in patients with HBV DNA between 2000–20,000 IU/ml

被引：0
|
作者：
Sibel Yıldız Kaya
Bilgül Mete
Abdurrahman Kaya
Ilker Inanç Balkan
Neşe Saltoglu
Ömer Fehmi Tabak
机构：
[1] Sungurlu State Hospital,Department of Infectious Disease
[2] Istanbul University-Cerrahpasa,Department of Infectious Disease, Medical School of Cerrahpasa
[3] Istanbul Training and Research Hospital,Department of Infectious Disease
来源：
Wiener klinische Wochenschrift | 2021年 / 133卷
关键词：
Quantitative; HBsAg; Hepatitis B; Chronic infection; Chronic hepatitis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：647 / 653
页数：6
相关论文
共 50 条
  • [31] Do HBsAg concentrations > 4 log10IU/ml represent a risk for mother to child transmission of HBV infection in all chronic hepatitis B patients?
    Carey, Ivana
    McLeod, Marie-Ange
    Bruce, Matthew
    Wang, Bo
    Gonsalkorala, Enoka
    Byrne, Ruth
    Dusheiko, Geoffrey M.
    Agarwal, Kosh
    HEPATOLOGY, 2017, 66 : 1007A - 1008A
  • [32] WHAT WOULD WE HAVE IF NAIVE HEPATITIS B PATIENTS WITH HBV-DNA LEVELS BELOW 2000 IU/ML WERE PERFORMED LIVER BIOPSY; THE RESULTS OF 85 YOUNG-MALE AND NAIVE PATIENTS
    Yenilmez, E.
    Cetinkaya, R. A.
    Afyon, M.
    Ulcay, A.
    Turhan, V.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S359 - S360
  • [33] Testing for Total HDV Antibodies in HBsAg Positive Patients with HBV-DNA Less Than 5 pg/mL by Hybrid Capture
    Ozekinci, Tuncer
    Akpolat, Nezahat
    Atmaca, Selahattin
    Elci, Saffet
    Mete, Mahmut
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2005, 10 (01): : 34 - 36
  • [34] Quantitative analysis of bleeding risk in cancer patients (pts) prophylactically transfused at platelet (plt) counts (cts) of 5,000, 10,000, or 20,000 plts/μl.
    Slichter, SJ
    LeBlanc, R
    Jones, MK
    Townsend-McCall, D
    Bolgiano, D
    Gemsheimer, T
    Nichol, J
    Stead, R
    BLOOD, 1999, 94 (10) : 376A - 377A
  • [35] Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients
    Zhang, Zhan-qing
    Shi, Bi-sheng
    Lu, Wei
    Liu, Dan-ping
    Huang, Dan
    Feng, Yan-ling
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2020, 43 (09): : 526 - 536
  • [36] HBEAG-POSITIVE PATIENTS WITH HBsAg <100 IU/ML AND NEGATIVE HBV RNA HAVE LOWER RISK OF VIROLOGICAL RELAPSE AFTER NUCLEOS(T)IDE ANALOGUES CESSATION
    Xie, Yandi
    Li, Minghui
    Ou, Xiaojuan
    Zheng, Sujun
    Gao, Yinjie
    Xu, Xiaoyuan
    Yang, Ying
    Ma, Anlin
    Li, Jia
    Huang, Yuan
    Nan, Yuemin
    Zheng, Huanwei
    Feng, Bo
    HEPATOLOGY, 2021, 74 : 483A - 484A
  • [37] 220例血清HBV DNA≤2 000 IU/mL的代偿期肝硬化患者肝功能评价指标、并发症分析
    皇旭
    刘文华
    卓豪
    张子恒
    郭忠胜
    于丽君
    孙丽华
    安勇
    山东医药, 2023, (06) : 28 - 32
  • [38] The association between serum anion gap and all-cause mortality of unselected adult patients: A retrospective cohort study of >20,000 patients
    Ji, Xuan
    Peng, Shixuan
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2023, 37 (01)
  • [39] Relationship between HBsAg, HBcAg expression and serum HBV DNA level in 140 patients with chronic hepatitis B
    Yan, Y.
    Mai, L.
    Lin, G. L.
    Liu, J.
    Zhu, J. Y.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S75 - S75
  • [40] Outcomes of transplantation for HBV- vs. HCV-related HCC: impact of DAA HCV therapy in a national analysis of >20,000 patients
    Tabrizian, Parissa
    Saberi, Behnam
    Holzner, Matthew L.
    Rocha, Chiara
    Jung, Yun Kyung
    Myers, Bryan
    Florman, Sander S.
    Schwartz, Myron E.
    HPB, 2022, 24 (07) : 1082 - 1090
12345